Insider Transactions in Q4 2022 at Global Blood Therapeutics, Inc. (GBT)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 05
2022
|
Scott W Morrison Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,637
-100.0%
|
-
|
Oct 05
2022
|
Mark L Perry Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
37,865
-100.0%
|
-
|
Oct 05
2022
|
Deval L Patrick Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,037
-100.0%
|
-
|
Oct 05
2022
|
Alexis A. Thompson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,308
-100.0%
|
-
|
Oct 05
2022
|
Wendy L Yarno Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,437
-100.0%
|
-
|
Oct 05
2022
|
Philip A. Pizzo Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,112
-100.0%
|
-
|
Oct 05
2022
|
Dawn Svoronos Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,376
-100.0%
|
-
|
Oct 05
2022
|
Glenn Pierce Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,437
-100.0%
|
-
|
Oct 05
2022
|
Kim Smith Whitley Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
5,980
-100.0%
|
-
|
Oct 05
2022
|
David Lee Johnson Chief Commercial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
34,384
-100.0%
|
-
|
Oct 05
2022
|
Ted W Love President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
346,300
-100.0%
|
-
|
Oct 05
2022
|
Ted W Love President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
576,318
-100.0%
|
-
|
Oct 05
2022
|
Nazila Habibizad Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,680
-100.0%
|
-
|
Oct 05
2022
|
Carrie Krehlik Chief Human Resources Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,716
-100.0%
|
-
|
Oct 05
2022
|
Tricia Borga Suvari Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
43,077
-100.0%
|
-
|
Oct 05
2022
|
Jeffrey S Farrow Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
26,739
-100.0%
|
-
|
Oct 05
2022
|
Jung Choi Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
25,000
-100.0%
|
-
|
Oct 05
2022
|
Jung Choi Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
226,672
-100.0%
|
-
|
Oct 01
2022
|
Nazila Habibizad Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,557
+1.91%
|
-
|